Clinical Presentation, Course, and Risk Factors Associated with Mortality in a Severe Outbreak of COVID-19 in Rhode Island, USA, April-June 2020.
COVID-19
LTCF
nursing homes
pandemic
Journal
Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317
Informations de publication
Date de publication:
24 Dec 2020
24 Dec 2020
Historique:
received:
07
11
2020
revised:
08
12
2020
accepted:
21
12
2020
entrez:
30
12
2020
pubmed:
31
12
2020
medline:
31
12
2020
Statut:
epublish
Résumé
Long-term care facilities (LTCFs) have had a disproportionally high mortality rate due to COVID-19. We describe a rapidly escalating COVID-19 outbreak among 116 LTCF residents in Rhode Island, USA. Overall, 111 (95.6%) residents tested positive and, of these, 48 (43.2%) died. The most common comorbidities were hypertension (84.7%) and cardiovascular disease (84.7%). A small percentage (9%) of residents were asymptomatic, while 33.3% of residents were pre-symptomatic, with progression to symptoms within a median of three days following the positive test. While typical symptoms of fever (80.2%) and cough (43.2%) were prevalent, shortness of breath (14.4%) was rarely found despite common hypoxemia (95.5%). The majority of patients demonstrated atypical symptoms with the most common being loss of appetite (61.3%), lethargy (42.3%), diarrhea (37.8%), and fatigue (32.4%). Many residents had increased agitation (38.7%) and anxiety (5.4%), potentially due to the restriction measures or the underlying mental illness. The fever curve was characterized by an intermittent low-grade fever, often the first presenting symptom. Mortality was associated with a disease course beginning with a loss of appetite and lethargy, as well as one more often involving fever greater than 38 °C, loss of appetite, altered mental status, diarrhea, and respiratory distress. Interestingly, no differences in age or comorbidities were noted between survivors and non-survivors. Taking demographic factors into account, treatment with anticoagulation was still associated with reduced mortality (adjusted OR 0.16; 95% C.I. 0.06-0.39;
Identifiants
pubmed: 33374131
pii: pathogens10010008
doi: 10.3390/pathogens10010008
pmc: PMC7824344
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Am Med Dir Assoc. 2020 Jul;21(7):905-908
pubmed: 32674817
Sci Rep. 2020 Nov 30;10(1):20834
pubmed: 33257703
J Am Med Dir Assoc. 2020 Oct;21(10):1378-1383.e1
pubmed: 32981664
Clin Infect Dis. 2000 Jul;31(1):148-51
pubmed: 10913413
JAMA Netw Open. 2020 Jul 1;3(7):e2015957
pubmed: 32697325
Sustain Cities Soc. 2020 Nov;62:102390
pubmed: 32834937
Acta Neuropathol. 2015 Apr;129(4):493-509
pubmed: 25537401
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):651-655
pubmed: 32463809
Clin Infect Dis. 2020 Jul 28;71(15):861-862
pubmed: 32201889
J Infect. 2020 Oct;81(4):647-679
pubmed: 32592704
J Am Geriatr Soc. 2020 Sep;68(9):1899-1906
pubmed: 32557542
Eur Geriatr Med. 2020 Dec;11(6):1085-1088
pubmed: 33025500
J Am Geriatr Soc. 2020 Aug;68(8):1647-1652
pubmed: 32633418
Eur Geriatr Med. 2020 Nov 27;:
pubmed: 33245505
Maturitas. 2020 Nov;141:46-52
pubmed: 33036702
JAMA. 2020 Sep 15;324(11):1103-1105
pubmed: 32790822
J Infect. 2020 Oct;81(4):621-624
pubmed: 32735893
Infect Control Hosp Epidemiol. 2020 Oct 26;:1-6
pubmed: 33100245
Clin Infect Dis. 2020 Dec 3;71(9):2311-2313
pubmed: 32628269
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1288-1295
pubmed: 32966272
JAMA. 2020 Jul 14;324(2):123-125
pubmed: 32525535
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17513-17515
pubmed: 32632012
Emerg Infect Dis. 2020 Oct;26(10):2416-2419
pubmed: 32614768
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1300-1304
pubmed: 32941409
J Infect. 2020 Sep;81(3):411-419
pubmed: 32504743
Mayo Clin Proc. 2020 Nov;95(11):2467-2486
pubmed: 33153635
JAMA. 2020 Jul 7;324(1):23-24
pubmed: 32442303
J Am Med Dir Assoc. 2020 Dec;21(12):1767-1773.e1
pubmed: 33153910
Am J Health Syst Pharm. 2020 Nov 16;77(23):1957-1960
pubmed: 32780839
JAMA. 2020 Jul 7;324(1):25-26
pubmed: 32501504
J Am Med Dir Assoc. 2020 Dec;21(12):1791-1797.e1
pubmed: 33256958
Clin Infect Dis. 2020 Aug 28;:
pubmed: 32857130
Respir Med Case Rep. 2020;31:101186
pubmed: 32834989
J Clin Nurs. 2020 Aug;29(15-16):2758-2759
pubmed: 32281165